SIGA - SIGA Technologies, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
New York,
United States
Type: Equity
SIGA price evolution
SIGA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $106.95 | $143.87 | $150.15 | |
| Short term investments | ||||
| Net receivables | $12.09 | $8.95 | $18.13 | $21.13 |
| Inventory | $62.02 | $55.66 | $63.72 | $64.22 |
| Total current assets | $180.69 | $176.48 | $227.89 | $238.99 |
| Long term investments | ||||
| Property, plant & equipment | $1.41 | $1.52 | $1.19 | $1.33 |
| Goodwill & intangible assets | $0.9 | $0.9 | $0.9 | |
| Total noncurrent assets | $16.18 | $15.25 | $15.36 | |
| Total investments | ||||
| Total assets | $195.35 | $192.66 | $243.15 | $254.35 |
| Current liabilities | ||||
| Accounts payable | $1.26 | $1.03 | $2.52 | $1.46 |
| Deferred revenue | $13.73 | $20.79 | $20.79 | |
| Short long term debt | ||||
| Total current liabilities | $22.3 | $21.38 | $74.81 | $54.12 |
| Long term debt | ||||
| Total noncurrent liabilities | $3.72 | $3.34 | $3.38 | |
| Total debt | ||||
| Total liabilities | $25.91 | $25.1 | $78.16 | $57.49 |
| Shareholders' equity | ||||
| Retained earnings | -$68.6 | -$69.95 | -$71.78 | -$38.94 |
| Other shareholder equity | ||||
| Total shareholder equity | $167.56 | $164.99 | $196.86 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $150.15 | $98.79 | $103.14 | $117.89 |
| Short term investments | ||||
| Net receivables | $21.13 | $45.41 | $83.65 | $3.34 |
| Inventory | $64.22 | $39.27 | $19.51 | $20.27 |
| Total current assets | $238.99 | $185.79 | $208.75 | $143.61 |
| Long term investments | ||||
| Property, plant & equipment | $1.33 | $1.85 | $2.37 | $2.1 |
| Goodwill & intangible assets | $0.9 | $0.9 | $0.9 | $0.9 |
| Total noncurrent assets | $15.36 | $9.25 | $5.97 | $6.22 |
| Total investments | ||||
| Total assets | $254.35 | $195.04 | $214.73 | $149.83 |
| Current liabilities | ||||
| Accounts payable | $1.46 | $3.36 | $2.03 | $1.28 |
| Deferred revenue | $20.79 | |||
| Short long term debt | ||||
| Total current liabilities | $54.12 | $21.52 | $30.49 | $10.48 |
| Long term debt | ||||
| Total noncurrent liabilities | $3.38 | $3.36 | $9.92 | $9.55 |
| Total debt | ||||
| Total liabilities | $57.49 | $24.88 | $40.41 | $20.04 |
| Shareholders' equity | ||||
| Retained earnings | -$38.94 | -$63.8 | -$51.76 | -$95.19 |
| Other shareholder equity | ||||
| Total shareholder equity | $196.86 | $170.16 | $174.31 | $129.79 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $21.81 | $25.43 | $116.48 | |
| Cost of revenue | $12.31 | $3.23 | $14.8 | |
| Gross Profit | $9.5 | $22.2 | $101.68 | |
| Operating activities | ||||
| Research & development | $2.89 | $3.05 | $2.62 | |
| Selling, general & administrative | $5.53 | $7.88 | $7.38 | |
| Total operating expenses | $8.42 | $10.93 | $10 | |
| Operating income | $1.08 | $11.28 | $91.68 | |
| Income from continuing operations | ||||
| EBIT | $2.4 | $13.22 | $92.87 | |
| Income tax expense | $0.57 | $2.94 | $20.61 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $1.83 | $10.28 | $72.26 | |
| Income (for common shares) | $1.83 | $10.28 | $72.26 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $139.92 | $110.78 | $133.67 | $124.96 |
| Cost of revenue | $17.83 | $10.43 | $16.6 | $14.8 |
| Gross Profit | $122.09 | $100.34 | $117.07 | $110.16 |
| Operating activities | ||||
| Research & development | $16.43 | $22.53 | $9.94 | $10.94 |
| Selling, general & administrative | $22.04 | $35.12 | $17.32 | $14 |
| Total operating expenses | $38.47 | $57.64 | $27.98 | $25.66 |
| Operating income | $83.62 | $42.7 | $89.09 | $84.5 |
| Income from continuing operations | ||||
| EBIT | $87.78 | $44.13 | $89.31 | $76.53 |
| Income tax expense | $19.71 | $10.23 | $19.86 | $17.17 |
| Interest expense | $3.02 | |||
| Net income | ||||
| Net income | $68.07 | $33.9 | $69.45 | $56.34 |
| Income (for common shares) | $68.07 | $33.9 | $69.45 | $56.34 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $1.83 | $10.28 | $72.26 | |
| Operating activities | ||||
| Depreciation | $0.14 | $0.14 | $0.14 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.93 | $1.13 | $0.46 | |
| Total cash flows from operations | $5.95 | -$6.12 | $79.03 | |
| Investing activities | ||||
| Capital expenditures | -$0 | |||
| Investments | ||||
| Total cash flows from investing | -$0.02 | -$0 | ||
| Financing activities | ||||
| Dividends paid | -$42.67 | -$42.67 | ||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$43.3 | -$42.87 | -$0.16 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$50.88 | -$36.92 | -$6.28 | $79.03 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $68.07 | $33.9 | $69.45 | $56.34 |
| Operating activities | ||||
| Depreciation | $0.54 | $0.52 | $0.52 | $0.53 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.05 | $1.78 | $1.27 | $1.35 |
| Total cash flows from operations | $94.8 | $41.61 | $11.49 | $71.52 |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.05 | -$0.02 | |
| Investments | ||||
| Total cash flows from investing | -$0.02 | -$0.05 | -$0.02 | |
| Financing activities | ||||
| Dividends paid | -$32.14 | -$32.94 | ||
| Sale and purchase of stock | -$11.07 | -$13.01 | -$26.02 | -$28.5 |
| Net borrowings | -$85.91 | |||
| Total cash flows from financing | -$43.42 | -$45.96 | -$26.2 | -$114.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $51.36 | -$4.35 | -$14.75 | -$43.1 |
News
Fundamentals
| Market cap | $443.20M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 71.37M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.29 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 8.10 |
| Quick ratio | 5.32 |